Robb Knie - 27 Aug 2025 Form 4 Insider Report for Hoth Therapeutics, Inc. (HOTH)

Reporting relationship: CEO and President, Director
Issuer ticker: HOTH
Reported as of: 27 Aug 2025
Net transaction value: -$376,000
SEC form: 4
Accepted by SEC: 28 Aug 2025, 18:48:36 UTC
Prior SEC filing: 15 Jan 2025
Next SEC filing: 28 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Hayley Springer as Attorney-In-Fact for Robb Knie

Key filing fact

Robb Knie filed Form 4 for Hoth Therapeutics, Inc. (HOTH) on 28 Aug 2025.

Key facts

This page summarizes Robb Knie's Form 4 filing for Hoth Therapeutics, Inc. (HOTH).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 28 Aug 2025, 18:48.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001609695 Primary reporting owner

Relationship: CEO and President, Director
Address: C/O HOTH THERAPEUTICS, INC. 1177 AVENUE, OF THE AMERICAS, 5TH FLOOR, SUITE 5066, NEW YORK
Signature: /s/ Hayley Springer as Attorney-In-Fact for Robb Knie
Signature date: 28 Aug 2025

Shares, units, or other non-derivative securities reported in this filing.

HOTH transaction

Award

HOTH transaction

Tax liability

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

The restricted stock was issued pursuant to the Issuer's Amended and Restated 2022 Equity Incentive Plan, as amended, and vested in full upon grant.